They found that enhancing the number of dendritic cells, a type of immune cell, using Flt3-Ligand (Flt3-L), in combination with radiation therapy, resulted in impaired growth of both the irradiated tumor and the non-irradiated tumor in mice. Here, FLT3LG is linked to neoplasm.